MESO
Price
$16.12
Change
+$0.12 (+0.75%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
2.06B
Earnings call today
QTTB
Price
$1.75
Change
-$0.07 (-3.85%)
Updated
Aug 27, 04:56 PM (EDT)
Capitalization
20.98M
Interact to see
Advertisement

MESO vs QTTB

Header iconMESO vs QTTB Comparison
Open Charts MESO vs QTTBBanner chart's image
Mesoblast
Price$16.12
Change+$0.12 (+0.75%)
Volume$2.29K
Capitalization2.06B
Q32 Bio
Price$1.75
Change-$0.07 (-3.85%)
Volume$613
Capitalization20.98M
MESO vs QTTB Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. QTTB commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and QTTB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (MESO: $16.12 vs. QTTB: $1.72)
Brand notoriety: MESO and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 79% vs. QTTB: 6%
Market capitalization -- MESO: $2.06B vs. QTTB: $20.98M
MESO [@Biotechnology] is valued at $2.06B. QTTB’s [@Biotechnology] market capitalization is $20.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 4 TA indicator(s) are bullish while QTTB’s TA Score has 3 bullish TA indicator(s).

  • MESO’s TA Score: 4 bullish, 4 bearish.
  • QTTB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MESO is a better buy in the short-term than QTTB.

Price Growth

MESO (@Biotechnology) experienced а +7.40% price change this week, while QTTB (@Biotechnology) price change was -7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($2.07B) has a higher market cap than QTTB($21M). MESO YTD gains are higher at: -19.192 vs. QTTB (-47.093). QTTB has higher annual earnings (EBITDA): -33.17M vs. MESO (-77.78M). QTTB has more cash in the bank: 54.8M vs. MESO (37.7M). QTTB has less debt than MESO: QTTB (18.7M) vs MESO (126M). MESO has higher revenues than QTTB: MESO (5.67M) vs QTTB (0).
MESOQTTBMESO / QTTB
Capitalization2.07B21M9,833%
EBITDA-77.78M-33.17M234%
Gain YTD-19.192-47.09341%
P/E RatioN/AN/A-
Revenue5.67M0-
Total Cash37.7M54.8M69%
Total Debt126M18.7M674%
FUNDAMENTALS RATINGS
MESO vs QTTB: Fundamental Ratings
MESO
QTTB
OUTLOOK RATING
1..100
748
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (42) in the null industry is somewhat better than the same rating for MESO (87) in the Biotechnology industry. This means that QTTB’s stock grew somewhat faster than MESO’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as MESO (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to MESO’s over the last 12 months.

MESO's SMR Rating (96) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

MESO's Price Growth Rating (39) in the Biotechnology industry is in the same range as QTTB (64) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESOQTTB
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUERX15.39N/A
N/A
Auer Growth
IGVWX52.20N/A
N/A
Voya Global High Dividend Low Vol W
FIKEX59.53N/A
N/A
Fidelity Advisor Industrials Z
ACESX11.20N/A
N/A
Invesco Equity and Income R
PAADX17.18N/A
N/A
Putnam Dynamic Asset Allocation Bal R5

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+1.85%
QTTB - MESO
51%
Loosely correlated
-7.61%
TNGX - MESO
33%
Poorly correlated
-0.60%
AVTX - MESO
32%
Poorly correlated
+1.06%
ZURA - MESO
32%
Poorly correlated
-0.98%
RAPT - MESO
30%
Poorly correlated
+3.72%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-7.61%
CLRB - QTTB
66%
Loosely correlated
+1.28%
MESO - QTTB
51%
Loosely correlated
+1.85%
STOK - QTTB
49%
Loosely correlated
+2.65%
ADCT - QTTB
47%
Loosely correlated
+2.59%
ANAB - QTTB
40%
Loosely correlated
-0.70%
More